This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Swiss Transplant Cohort Study (STCS)

This study is currently recruiting participants.
See Contacts and Locations
Verified January 2017 by Nicolas Mueller, University of Zurich
Sponsor:
Collaborators:
University of Bern
University of Basel
University of Lausanne
Cantonal Hospital of St. Gallen
University Hospital, Geneva
Information provided by (Responsible Party):
Nicolas Mueller, University of Zurich
ClinicalTrials.gov Identifier:
NCT01204944
First received: September 16, 2010
Last updated: January 3, 2017
Last verified: January 2017
  Purpose
The Swiss Transplant Cohort Study is an observational prospective cohort study enrolling all patients after solid organ and stem cell transplantation since 5/2008 in Switzerland. Predefined variables are collected at defined time points. Individual samples (PBMC, plasma, DNA) will be stored for future projects. Data relevant to transplantation outcome with emphasis on immunological and infectious complications as well as psychosocial variables will be gathered.

Condition
All Transplanted Individuals in Switzerland

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Swiss Transplant Cohort Study

Further study details as provided by Nicolas Mueller, University of Zurich:

Primary Outcome Measures:
  • Outcome after transplantation [ Time Frame: open ]
    Various endpoints


Estimated Enrollment: 7500
Study Start Date: May 2008
Estimated Study Completion Date: May 2018
Estimated Primary Completion Date: May 2018 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   up to 100 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
All transplanted indivduals in Switzerland
Criteria

Inclusion criteria:

  • All patients after organ and stem cell (planned 2009) transplantation.

Exclusion criteria:

  • No informed consent given
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01204944

Contacts
Contact: 01 Studienregister MasterAdmins +41 (0)44 255 11 11

Locations
Switzerland
Recruiting
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
University of Bern
University of Basel
University of Lausanne
Cantonal Hospital of St. Gallen
University Hospital, Geneva
Investigators
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
  More Information

Responsible Party: Nicolas Mueller, Head, Zurich University Hospital Transplant Center, University of Zurich
ClinicalTrials.gov Identifier: NCT01204944     History of Changes
Other Study ID Numbers: 3347C0-108795/1
Study First Received: September 16, 2010
Last Updated: January 3, 2017

ClinicalTrials.gov processed this record on August 17, 2017